Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06600 | 32812775 | Am J Physiol Gastrointest Liver Physiol | Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity. | 2020 | Details |
| A06615 | 32807638 | Nutr Metab Cardiovasc Dis | Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06619 | 32805210 | Chem Biol Interact | High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. | 2020 | Details |
| A06621 | 32805205 | Lancet Gastroenterol Hepatol | Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial. | 2020 | Details |
| A06627 | 32801462 | J Clin Biochem Nutr | Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids. | 2020 | Details |
| A06628 | 32801031 | J Nutr Biochem | Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. | 2020 | Details |
| A06639 | 32798261 | Phytother Res | The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial. | 2020 | Details |
| A06651 | 32794259 | Hepatology | The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH. | 2020 | Details |
| A06661 | 32791115 | Cell Host Microbe | Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. | 2020 | Details |
| A06663 | 32790577 | Physiol Rev | Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging. | 2020 | Details |
| A06669 | 32786868 | J Agric Food Chem | Fermented Soy Paste Alleviates Lipid Accumulation in the Liver by Regulating the AMPK Pathway and Modulating Gut Microbiota in High-Fat-Diet-Fed Rats. | 2020 | Details |
| A06677 | 32783933 | Cell Rep | Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis. | 2020 | Details |
| A06683 | 32781293 | Comp Biochem Physiol C Toxicol Pharmacol | Higher intestinal and circulatory lactate associated NOX2 activation leads to an ectopic fibrotic pathology following microcystin co-exposure in murine fatty liver disease. | 2020 | Details |
| A06707 | 32774711 | Am J Transl Res | Changes and roles of intestinal fungal microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. | 2020 | Details |
| A06740 | 32764281 | Nutrients | The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. | 2020 | Details |
| A06745 | 32762830 | J Pharm Pharm Sci | Cannabis and the Gastrointestinal Tract. | 2020 | Details |
| A06752 | 32759852 | Int J Mol Sci | Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A06756 | 32758573 | Eur J Pharmacol | Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways. | 2020 | Details |
| A06763 | 32756323 | J Clin Med | Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. | 2020 | Details |
| A06792 | 32744096 | Am J Physiol Endocrinol Metab | Neurodegeneration in juvenile Iberian pigs with diet-induced nonalcoholic fatty liver disease. | 2020 | Details |
| A06795 | 32742358 | Exp Ther Med | Pathophysiology of hepatic Na+/H+ exchange (Review). | 2020 | Details |
| A06801 | 32740097 | J Clin Gastroenterol | Renal Failure is Associated With Increased Mortality and Hospital Utilization in Patients Admitted With Nonalcoholic Steatohepatitis. | 2021 | Details |
| A06810 | 32738185 | Mol Nutr Food Res | The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06835 | 32730664 | Liver Int | Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease. | 2020 | Details |
| A06862 | 32718371 | Br J Nutr | Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway. | 2020 | Details |
| A06863 | 32718364 | Br J Nutr | Lactobacillus casei YRL577 combined with plant extracts reduce markers of non-alcoholic fatty liver disease in mice. | 2020 | Details |
| A06866 | 32717871 | Int J Mol Sci | Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications. | 2020 | Details |
| A06872 | 32715667 | J Korean Med Sci | Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea. | 2020 | Details |
| A06918 | 32698063 | Int J Biol Macromol | Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. | 2020 | Details |
| A06932 | 32694791 | Nat Metab | The small intestine shields the liver from fructose-induced steatosis. | 2020 | Details |
| A06936 | 32694178 | Gut | Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. | 2020 | Details |
| A06952 | 32688217 | J Nutr Biochem | Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota. | 2020 | Details |
| A06993 | 32668632 | Int J Mol Sci | Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone? | 2020 | Details |
| A06996 | 32666969 | Food Funct | Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD. | 2020 | Details |
| A07000 | 32665525 | Gastroenterol Nurs | Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis. | 2021 | Details |
| A07003 | 32663815 | J Breath Res | High intestinal hydrogen production in runners after intake of fructose solution. | 2020 | Details |
| A07012 | 32659827 | Z Gastroenterol | [Choosing wisely - perspectives: what are the key questions?] | 2020 | Details |
| A07029 | 32652744 | Liver Int | MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study. | 2020 | Details |
| A07030 | 32652145 | Gastroenterology | Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07037 | 32649507 | Chin Med J (Engl) | Intestinal epithelial chemokine (C-C motif) ligand 7 overexpression protects against high fat diet-induced obesity and hepatic steatosis in mice. | 2020 | Details |
| A07050 | 32641615 | J Oleo Sci | Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota. | 2020 | Details |
| A07051 | 32640454 | Pharmacology | Molecular Study on the Potential Protective Effects of Bee Venom against Fructose-Induced Nonalcoholic Steatohepatitis in Rats. | 2020 | Details |
| A07053 | 32640105 | J Intern Med | A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study. | 2020 | Details |
| A07102 | 32621970 | Clin Gastroenterol Hepatol | Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease. | 2020 | Details |
| A07112 | 32618656 | Am J Gastroenterol | Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial. | 2020 | Details |
| A07116 | 32617026 | Hepat Med | Effect of Oral Administration of Weissella confusa on Fecal and Plasma Ethanol Concentrations, Lipids and Glucose Metabolism in Wistar Rats Fed High Fructose and Fat Diet. | 2020 | Details |
| A07129 | 32610095 | Cell Metab | A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. | 2020 | Details |
| A07152 | 32598715 | Ter Arkh | [Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease]. | 2020 | Details |
| A07154 | 32598594 | Ter Arkh | [Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development]. | 2019 | Details |
| A07192 | 32587515 | Front Pharmacol | Integrated Metagenomic and Metabolomic Analyses of the Effect of Astragalus Polysaccharides on Alleviating High-Fat Diet-Induced Metabolic Disorders. | 2020 | Details |
| A07215 | 32579743 | Mol Nutr Food Res | Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein Diet. | 2020 | Details |
| A07216 | 32579269 | J Gastroenterol Hepatol | High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A07219 | 32577775 | Inflamm Res | Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease. | 2020 | Details |
| A07223 | 32576050 | Gut Microbes | Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice. | 2020 | Details |
| A07230 | 32573567 | Food Funct | Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways. | 2020 | Details |
| A07244 | 32569680 | Metabolism | Metabolic liver disease in diabetes - From mechanisms to clinical trials. | 2020 | Details |
| A07247 | 32568734 | J Pediatr Endocrinol Metab | Definition and early diagnosis of metabolic syndrome in children. | 2020 | Details |
| A07265 | 32561908 | J Clin Endocrinol Metab | Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth. | 2020 | Details |
| A07268 | 32559768 | Horm Metab Res | Effects and Safety of Sitagliptin in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A07295 | 32553151 | Lancet Gastroenterol Hepatol | Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. | 2020 | Details |
| A07320 | 32540565 | Environ Pollut | Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice. | 2020 | Details |
| A07321 | 32540177 | J Hepatol | Blocking integrin α4β7-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis. | 2020 | Details |
| A07322 | 32538722 | Curr Protein Pept Sci | Gut Barrier Proteins Mediate Liver Regulation by the Effects of Serotonin on the Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07325 | 32536770 | World J Gastroenterol | Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. | 2020 | Details |
| A07326 | 32536582 | Clin Nutr | Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults. | 2020 | Details |
| A07340 | 32531370 | Int J Biol Macromol | The protective effects of walnut green husk polysaccharide on liver injury, vascular endothelial dysfunction and disorder of gut microbiota in high fructose-induced mice. | 2020 | Details |
| A07357 | 32526796 | Mol Nutr Food Res | Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism. | 2020 | Details |
| A07366 | 32524395 | Chin J Integr Med | Intestinal Microecology: An Important Target for Chinese Medicine Treatment of Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A07372 | 32523311 | World J Gastroenterol | Role of γδT cells in liver diseases and its relationship with intestinal microbiota. | 2020 | Details |
| A07373 | 32523101 | Sci Rep | Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools. | 2020 | Details |
| A07387 | 32518225 | Nutr Diabetes | Consumption of a high energy density diet triggers microbiota dysbiosis, hepatic lipidosis, and microglia activation in the nucleus of the solitary tract in rats. | 2020 | Details |
| A07392 | 32516028 | Am J Physiol Endocrinol Metab | NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice. | 2020 | Details |
| A07408 | 32512581 | PLoS One | Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet. | 2020 | Details |
| A07424 | 32505776 | Clin Chim Acta | Intestinal microbiota-farnesoid X receptor axis in metabolic diseases. | 2020 | Details |
| A07426 | 32504921 | Biomed Pharmacother | The influence of probiotics on bile acids in diseases and aging. | 2020 | Details |
| A07436 | 32497536 | Metabolism | Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance. | 2020 | Details |
| A07451 | 32490750 | Physiology (Bethesda) | Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? | 2020 | Details |
| A07469 | 32483408 | EXCLI J | Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism. | 2020 | Details |
| A07471 | 32483129 | Sci Rep | Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A07486 | 32476787 | World J Gastroenterol | Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα. | 2020 | Details |
| A07569 | 32440680 | Inflamm Bowel Dis | Multidimensional Impact of Mediterranean Diet on IBD Patients. | 2021 | Details |
| A07589 | 32433419 | Eur J Gastroenterol Hepatol | Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system. | 2021 | Details |
| A07591 | 32432142 | World J Clin Cases | Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature. | 2020 | Details |
| A07618 | 32418749 | Ann Hepatol | A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management. | 2020 | Details |
| A07622 | 32417163 | Chem Biol Interact | Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein. | 2020 | Details |
| A07624 | 32416862 | Lancet Gastroenterol Hepatol | The effect of sleep on gastrointestinal functioning in common digestive diseases. | 2020 | Details |
| A07666 | 32403887 | Zhonghua Gan Zang Bing Za Zhi | [Discussion on the curative effect and mechanisms of berberine in rats with non-alcoholic fatty liver]. | 2020 | Details |
| A07686 | 32390701 | World J Gastroenterol | Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. | 2020 | Details |
| A07689 | 32390455 | Antioxid Redox Signal | Intestinal Dysbiosis and Development of Cardiometabolic Disorders in Childhood Cancer Survivors: A Critical Review. | 2020 | Details |
| A07697 | 32388250 | J Nutr Biochem | Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis. | 2020 | Details |
| A07706 | 32383865 | J Agric Food Chem | Protective Mechanism of Common Buckwheat (Fagopyrum esculentum Moench.) against Nonalcoholic Fatty Liver Disease Associated with Dyslipidemia in Mice Fed a High-Fat and High-Cholesterol Diet. | 2020 | Details |
| A07746 | 32366600 | J Pharmacol Exp Ther | Ezetimibe Markedly Reduces Hepatic Triglycerides and Cholesterol in Rats Fed on Fish Oil by Increasing the Expression of Cholesterol Efflux Transporters. | 2020 | Details |
| A07776 | 32357561 | Int J Mol Sci | The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement. | 2020 | Details |
| A07777 | 32357501 | Nutrients | Assessing Non-Invasive Liver Function in Patients with Intestinal Failure Receiving Total Parenteral Nutrition-Results from the Prospective PNLiver Trial. | 2020 | Details |
| A07797 | 32352707 | Clin Transl Gastroenterol | Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC. | 2020 | Details |
| A07833 | 32340286 | Int J Mol Sci | Nutrition and Genetics in NAFLD: The Perfect Binomium. | 2020 | Details |
| A07846 | 32336663 | Surg Obes Relat Dis | Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review. | 2020 | Details |
| A07850 | 32335723 | Appl Microbiol Biotechnol | Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. | 2020 | Details |
| A07853 | 32333910 | Gastroenterology | Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease. | 2020 | Details |
| A07867 | 32329657 | Gut Microbes | Microbial and metabolic impacts of trehalose and trehalose analogues. | 2020 | Details |